C4 Therapeutics, Inc.
C4 Therapeutics, Inc. scores highest on Nitro (55) and lowest on Anchor (29). Its PosiPenta is 39.88 out of 100, weaker than most similar companies.
On the Penta Grid this week, C4 Therapeutics, Inc. is Grid #545 of 837 in the Healthcare sector in United States, and Grid #2,898 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | 39.88 | 34 | 36 | 55 | 45 | 29 |
| Senseonics Holdings, Inc. | 39.33 | 15 | 30 | 73 | 24 | 54 |
| Embecta Corp. | 61.87 | 43 | 61 | 48 | 97 | 60 |
| Indaptus Therapeutics, Inc. | 41.18 | 2 | 41 | 50 | 49 | 63 |
| Carlsmed, Inc. | 45.64 | 16 | 31 | 78 | 40 | 64 |
| Avalo Therapeutics, Inc. | 42.70 | 35 | 32 | 25 | 70 | 51 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.04 |
| P/B ratio | 1.38 |
EEarnings
| Trailing EPS | ₹-86.19 |
| Forward EPS | ₹-91.12 |
NNitro
| Price | 261.89 |
| 52-week high | 489.68 |
| 52-week low | 160.07 |
| Fall from 52-week high | 46.5% |
TTorque
| Return on equity (ROE) | -48.14% |
| Debt-to-equity | 0.23 |
AAnchor
| Beta (price swings) | 3.08 |
| Market cap | ₹3,221 Cr |
| Insider holding | 0.84% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is C4 Therapeutics, Inc.'s PosiPenta score?
C4 Therapeutics, Inc.'s PosiPenta is 39.88 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does C4 Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, C4 Therapeutics, Inc. is Grid #545 of 837 in the Healthcare sector in United States, and Grid #2,898 of 4,000 in United States.
Which PosiPenta pillar is strongest for C4 Therapeutics, Inc.?
Nitro (momentum), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for C4 Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 29 out of 100: weaker than most similar companies.
Has C4 Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.99 points, from 35.89 to 39.88.
PositoAI is for research and education only and is not investment advice.